|
ARID4B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.37949998488563E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.78779999979473E-07 |
| Normal-vs-Stage2 |
3.09180000046538E-07 |
| Normal-vs-Stage3 |
2.08289999692468E-08 |
| Normal-vs-Stage4 |
2.7416000003555E-07 |
| Stage1-vs-Stage2 |
1.300410E-01 |
| Stage1-vs-Stage3 |
1.712170E-01 |
| Stage1-vs-Stage4 |
2.186600E-01 |
| Stage2-vs-Stage3 |
6.224000E-01 |
| Stage2-vs-Stage4 |
7.746600E-01 |
| Stage3-vs-Stage4 |
8.528400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.24839996305116E-09 |
| Normal-vs-AfricanAmerican |
4.338300E-02 |
| Normal-vs-Asian |
4.25569999999986E-05 |
| Caucasian-vs-AfricanAmerican |
8.817900E-02 |
| Caucasian-vs-Asian |
6.897200E-01 |
| AfricanAmerican-vs-Asian |
2.071200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.7102999540557E-09 |
| Normal-vs-Female |
4.09770000153742E-08 |
| Male-vs-Female |
5.397800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.52029999994841E-06 |
| Normal-vs-Age(41-60Yrs) |
5.02039999572546E-08 |
| Normal-vs-Age(61-80Yrs) |
6.5244000202469E-09 |
| Normal-vs-Age(81-100Yrs) |
3.041300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.455400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.966200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.269400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.031600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.745800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.036400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.975000E-03 |
| Classical-VS-Follicular |
7.67000000000406E-05 |
| Classical-VS-Other |
4.370400E-01 |
| Classical-VS-Normal |
4.7707000000452E-06 |
| Tall-VS-Follicular |
8.585200E-01 |
| Tall-VS-Other |
5.831000E-01 |
| Tall-VS-Normal |
5.20039999951649E-08 |
| Follicular-VS-Other |
5.904200E-01 |
| Follicular-VS-Normal |
4.56400028880921E-10 |
| Other-VS-Normal |
1.605810E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.30489996585936E-09 |
| Normal-vs-N1 |
2.05349999999882E-05 |
| N0-vs-N1 |
5.247200E-01 |
|
|
